Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
- PMID: 29880119
- DOI: 10.1016/j.jacc.2018.03.519
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Abstract
Background: Long-term continuous monitoring detects short-lasting, subclinical atrial fibrillation (SCAF) in approximately one-third of older individuals with cardiovascular conditions. The relationship between SCAF, its progression, and the development of heart failure (HF) is unclear.
Objectives: This study examined the relationship between progression from shorter to longer SCAF episodes and HF hospitalization.
Methods: Subjects in ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial) were ≥65 years old, had history of hypertension, no prior clinical AF, and an implanted pacemaker or defibrillator. We examined patients whose longest SCAF episode during the first year after enrollment was >6 min but ≤24 h (n = 415). Using time-dependent Cox models, we evaluated the relationship between subsequent development of SCAF >24 h or clinical AF and HF hospitalization.
Results: Over a mean follow-up of 2 years, 65 patients (15.7%) progressed to having SCAF episodes >24 h or clinical AF (incidence 8.8% per year). Older age, greater body mass index, and longer SCAF duration within the first year were independent predictors of SCAF progression. The rate of HF hospitalization among patients with SCAF progression was 8.9% per year compared with 2.5% per year for those without progression. After multivariable adjustment, SCAF progression was independently associated with HF hospitalization (hazard ratio [HR]: 4.58; 95% confidence interval [CI]: 1.64 to 12.80; p = 0.004). Similar results were observed when we excluded patients with prior history of HF (HR: 7.06; 95% CI: 1.82 to 27.30; p = 0.005) or when SCAF progression was defined as development of SCAF >24 h alone (HR: 3.68; 95% CI: 1.27 to 10.70; p = 0.016).
Conclusions: In patients with a pacemaker or defibrillator, SCAF progression was strongly associated with HF hospitalization.
Keywords: atrial fibrillation; atrial fibrillation progression; health outcome; heart failure; predictors; subclinical atrial fibrillation.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Cacophony of Silent Atrial Fibrillation.J Am Coll Cardiol. 2018 Jun 12;71(23):2612-2615. doi: 10.1016/j.jacc.2018.03.520. J Am Coll Cardiol. 2018. PMID: 29880120 No abstract available.
Similar articles
-
Temporal relationship between subclinical atrial fibrillation and embolic events.Circulation. 2014 May 27;129(21):2094-9. doi: 10.1161/CIRCULATIONAHA.113.007825. Epub 2014 Mar 14. Circulation. 2014. PMID: 24633881 Clinical Trial.
-
Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT).Am Heart J. 2018 Jul;201:160-163. doi: 10.1016/j.ahj.2018.03.027. Epub 2018 Apr 18. Am Heart J. 2018. PMID: 29764671 Clinical Trial.
-
Subclinical Atrial Fibrillation in Older Patients.Circulation. 2017 Oct 3;136(14):1276-1283. doi: 10.1161/CIRCULATIONAHA.117.028845. Epub 2017 Aug 4. Circulation. 2017. PMID: 28778946
-
Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.Europace. 2015 Oct;17 Suppl 2:ii40-6. doi: 10.1093/europace/euv235. Europace. 2015. PMID: 26842114 Review.
-
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.Medicina (Kaunas). 2019 Sep 20;55(10):611. doi: 10.3390/medicina55100611. Medicina (Kaunas). 2019. PMID: 31547078 Free PMC article. Review.
Cited by
-
Complexity AF score as a novel marker of atrial fibrillation instability.Sci Rep. 2024 Nov 13;14(1):27833. doi: 10.1038/s41598-024-76611-7. Sci Rep. 2024. PMID: 39537673 Free PMC article.
-
Performance of Ambulatory Electrocardiographic Data for Prediction of Stroke and Heart Failure Events.JACC Adv. 2024 Oct 18;3(11):101340. doi: 10.1016/j.jacadv.2024.101340. eCollection 2024 Nov. JACC Adv. 2024. PMID: 39497946 Free PMC article.
-
[MVP Risk score and new atrial fibrillation diagnosis: Prospective cohort PREFATE study].Aten Primaria. 2024 Sep 11;57(1):103071. doi: 10.1016/j.aprim.2024.103071. Online ahead of print. Aten Primaria. 2024. PMID: 39265318 Free PMC article. Spanish.
-
Clinical impact of atrial fibrillation progression in patients with heart failure with preserved ejection fraction: A report from the CHART-2 Study.Europace. 2024 Aug 30;26(9):euae218. doi: 10.1093/europace/euae218. Europace. 2024. PMID: 39150084 Free PMC article.
-
Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012842. doi: 10.1161/CIRCEP.124.012842. Epub 2024 Jun 28. Circ Arrhythm Electrophysiol. 2024. PMID: 38939945 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
